Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutations”.
H.-T. Arkenau, P. Funchain, A. Hervieu, K. Anthony, S.P. Chawla +8 more